Stanley-Laman Group’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$244K	Sell	3,531 -2,087	-37%	-$144K	0.04%	262
2025 Q1	$390K	Buy	+5,618	New	+$390K	0.06%	216
2024 Q4	–	Sell	-2,369	Closed	-$282K	–	293
2024 Q3	$282K	Buy	+2,369	New	+$282K	0.04%	242